<VariationArchive VariationID="14561" VariationName="NM_005562.3(LAMC2):c.3394dup (p.Thr1132fs)" VariationType="Duplication" Accession="VCV000014561" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2022-04-02" MostRecentSubmission="2022-04-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29600" VariationID="14561">
      <GeneList>
        <Gene Symbol="LAMC2" FullName="laminin subunit gamma 2" GeneID="3918" HGNC_ID="HGNC:6493" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="183186264" stop="183258968" display_start="183186264" display_stop="183258968" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="183155173" stop="183214261" display_start="183155173" display_stop="183214261" Strand="+" />
          </Location>
          <OMIM>150292</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005562.3(LAMC2):c.3394dup (p.Thr1132fs)</Name>
      <CanonicalSPDI>NC_000001.11:183243211:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="183243211" stop="183243212" display_start="183243211" display_stop="183243212" variantLength="1" positionVCF="183243211" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="183212346" stop="183212347" display_start="183212346" display_stop="183212347" variantLength="1" positionVCF="183212346" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>T1132fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.183212347dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.183212347dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.183243212dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.183243212dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007079.2" sequenceAccession="NG_007079" sequenceVersion="2" change="g.61949dup">
            <Expression>NG_007079.2:g.61949dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005562.3" sequenceAccession="NM_005562" sequenceVersion="3" change="c.3394dup" MANESelect="true">
            <Expression>NM_005562.3:c.3394dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005553.2" sequenceAccession="NP_005553" sequenceVersion="2" change="p.Thr1132fs">
            <Expression>NP_005553.2:p.Thr1132fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="150292.0008" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for allelic variant 150292.0008 from the sequence of the allele-specific oligonucleotide reported in the paper by Castiglia et al., 2001 (PubMed 11564184).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005562.3(LAMC2):c.3394dup (p.Thr1132fs) AND Epidermolysis bullosa, junctional 3A, intermediate" Accession="RCV002051628" Version="9">
        <ClassifiedConditionList TraitSetID="73931">
          <ClassifiedCondition DB="MedGen" ID="C5676938">Epidermolysis bullosa, junctional 3A, intermediate</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-04-02" MostRecentSubmission="2022-04-02">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11564184</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="73931" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="62003" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3A, GENERALIZED INTERMEDIATE</ElementValue>
                <XRef Type="MIM" ID="619785" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3A, NON-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="619785" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa, junctional 3A, intermediate</ElementValue>
                <XRef ID="MONDO:0030748" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">JEB3A</ElementValue>
                <XRef Type="MIM" ID="619785" DB="OMIM" />
              </Symbol>
              <XRef ID="C5676938" DB="MedGen" />
              <XRef ID="MONDO:0030748" DB="MONDO" />
              <XRef Type="MIM" ID="619785" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="35927" SubmissionDate="2022-03-29" DateLastUpdated="2022-04-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="150292.0008_EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3A, INTERMEDIATE" title="LAMC2, 1-BP INS, 3511A_EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3A, INTERMEDIATE" />
        <ClinVarAccession Accession="SCV000035927" DateUpdated="2022-04-02" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a compound heterozygous non-Herlitz junctional epidermolysis bullosa (JEB3A; 619785) patient, Castiglia et al. (2001) described a 1-basepair insertion (3511insA) in the 3-prime terminal exon of LAMC2, resulting in a frameshift and a premature termination codon. This mutation was predicted to lead to the synthesis of a gamma-2 polypeptide (gamma-2t) disrupted in its alpha-helical C-terminal structure and truncated of the last 25 amino acids. Transfection of this mutant cDNA into LAMC2-null keratinocytes failed to restore laminin-5 immunoreactivity, which indicated that integrity of the gamma-2 C-terminal amino acid sequences is required for laminin-5 assembly. The other allele of the patient carried a splice site mutation (150292.0007).</Attribute>
              <Citation>
                <ID Source="PubMed">11564184</ID>
              </Citation>
              <XRef DB="OMIM" ID="619785" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMC2" />
          </GeneList>
          <Name>LAMC2, 1-BP INS, 3511A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 3511A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="150292.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3A, INTERMEDIATE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="35927" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3A, INTERMEDIATE" MappingRef="Preferred">
        <MedGen CUI="C5676938" Name="Epidermolysis bullosa, junctional 3A, intermediate" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

